LOCOL Side Effects

6819823-4 | Foot Fracture
on Jun 28, 2010 Male patient from GERMANY , 58 years of age, was treated with Locol (View Usage). Patient experienced the following unwanted or unexpected effects: foot fracture. Locol dosage: . During the same period patient was treated with RASILEZ (View Rasilez Review and Rasilez Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

6678725-7 | Asthenia, Dysstasia, Fatigue, Haematocrit Decreased, Haemoglobin Decreased, Liver Disorder, Red Blood Cell Count Decreased, Renal Failure Acute
Patient was taking Locol (View Usage). Patient had the following side effects: asthenia, dysstasia, fatigue, haematocrit decreased, haemoglobin decreased, liver disorder, red blood cell count decreased, renal failure acute on Apr 07, 2010 from GERMANY Additional patient health information: Male patient , 64 years of age, was diagnosed with cardiovascular event prophylaxis, hypertension, prophylaxis against gastrointestinal ulcer and. Locol dosage: 80 Mg Per Day. During the same period patient was treated with EBRANTIL (60 Mg, Bid) (View Ebrantil Review and Ebrantil Label ), DIOVAN (80 Mg, Bid) (View Diovan Review and Diovan Label ), NEBILET (5 Mg, Unk) (View Nebilet Review and Nebilet Label ), DELIX (10 Mg, Qd) (View Delix Review and Delix Label ), TORSEMIDE (10 Mg, Qd) (View Torsemide Review and Torsemide Label ), CYNT (0.3 Mg, Bid) (View Cynt Review and Cynt Label ), PANTOPRAZOLE SODIUM (40 Mg, Qd) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6589989-2 | Osteolysis
Adverse event was reported on Feb 08, 2010 by a Male patient taking Locol (View Usage) (Dosage: 80mg Per Day) was diagnosed with hypercholesterolaemia, coronary artery disease (What is coronary artery disease?) and. Location: GERMANY , weighting 178.6 lb, After Locol was administered, patient had the following side effects: osteolysis. During the same period patient was treated with FORTZAAR (Unk) (View Fortzaar Review and Fortzaar Label ), CONCOR (Unk) (View Concor Review and Concor Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), EZETROL (Unk) (View Ezetrol Review and Ezetrol Label ), PANTOZOL (Unk) (View Pantozol Review and Pantozol Label ).

6589985-5 | Osteolysis
on Feb 08, 2010 Male patient from GERMANY , weighting 178.6 lb, was diagnosed with hypercholesterolaemia, coronary artery disease (What is coronary artery disease?) and was treated with Locol (View Usage). Patient experienced the following unwanted or unexpected effects: osteolysis. Locol dosage: 80mg Per Day. During the same period patient was treated with FORTZAAR (Unk) (View Fortzaar Review and Fortzaar Label ), CONCOR (Unk) (View Concor Review and Concor Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), EZETROL (Unk) (View Ezetrol Review and Ezetrol Label ), PANTOZOL (Unk) (View Pantozol Review and Pantozol Label ).


6557604-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Liver Disorder, Low Density Lipoprotein Increased
on Jan 15, 2010 Female patient from JAPAN , 70 years of age, was diagnosed with hypercholesterolaemia and was treated with Locol (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, liver disorder, low density lipoprotein increased. Locol dosage: 20 Mg/day.

6479737-9 | Blood Cholesterol Increased, Blood Glucose Increased, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Fall, Gait Disturbance, Gamma-glutamyltransferase Increased, High Density Lipoprotein Increased, Hip Surgery
Patient was taking Locol (View Usage). After Locol was administered, patient had the following side effects: blood cholesterol increased, blood glucose increased, blood lactate dehydrogenase increased, c-reactive protein increased, fall (What is fall?), gait disturbance, gamma-glutamyltransferase increased, high density lipoprotein increased, hip surgery on Nov 25, 2009 from GERMANY Additional patient health information: Female patient , 86 years of age, was diagnosed with blood cholesterol increased and. Locol dosage: 20 Mg Daily In Morning. During the same period patient was treated with CLEXANE (1-0-1) (View Clexane Review and Clexane Label ), ARTHROTEC (1-0-1) (View Arthrotec Review and Arthrotec Label ), PANTOZOL (1-0-0) (View Pantozol Review and Pantozol Label ), NITROFURANTOIN (1-0-1) (View Nitrofurantoin Review and Nitrofurantoin Label ), FOSAMAX (Once Per Week) (View Fosamax Review and Fosamax Label ), CALCIUM D3 (View Calcium D3 Review and Calcium D3 Label ), VERTIGOREL (1-0-0) (View Vertigorel Review and Vertigorel Label ). Patient was hospitalized.

6462065-5 | Blood Cholesterol Increased, Blood Glucose Increased, Blood Lactate Dehydrogenase Increased, Fall, Gamma-glutamyltransferase Increased, High Density Lipoprotein Increased, Hip Surgery, Knee Arthroplasty, Low Density Lipoprotein Increased
Adverse event was reported on Nov 17, 2009 by a Female patient taking Locol (View Usage) (Dosage: 20 Mg) was diagnosed with blood cholesterol increased and. Location: GERMANY , 86 years of age, Patient experienced the following unwanted or unexpected effects: blood cholesterol increased, blood glucose increased, blood lactate dehydrogenase increased, fall (What is fall?), gamma-glutamyltransferase increased, high density lipoprotein increased, hip surgery, knee arthroplasty, low density lipoprotein increased. During the same period patient was treated with ENOXAPARIN SODIUM (1-0-1) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), ARTHROTEC (1-0-1) (View Arthrotec Review and Arthrotec Label ), PANTOZOL (1-0-0) (View Pantozol Review and Pantozol Label ), NITROFURANTOIN (1-0-1) (View Nitrofurantoin Review and Nitrofurantoin Label ), FOSAMAX (Once Per Week) (View Fosamax Review and Fosamax Label ), CALCIUM D3 (View Calcium D3 Review and Calcium D3 Label ), VERTIGOREL (1-0-0) (View Vertigorel Review and Vertigorel Label ). Patient was hospitalized.

6461735-2 | Cerebral Hypoperfusion, Circulatory Collapse, Hepatitis Acute, Transaminases Increased
on Nov 16, 2009 Female patient from GERMANY , 69 years of age, weighting 136.7 lb, was diagnosed with thrombosis prophylaxis and was treated with Locol (View Usage). Patient had the following side effects: cerebral hypoperfusion, circulatory collapse, hepatitis acute, transaminases increased. Locol dosage: 80 Mg, Qd. During the same period patient was treated with MCP (10 Mg) (View Mcp Review and Mcp Label ), METOPROLOL SUCCINATE (47.5 Mg) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), ASPIRIN (100 Mg) (View Aspirin Review and Aspirin Label ), ASPISOL (500 Mg, Once/single) (View Aspisol Review and Aspisol Label ), PANTOZOL (40 Mg) (View Pantozol Review and Pantozol Label ), ENOXAPARIN SODIUM (8000 Iu, 1 Day) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized.

6410233-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Blood Calcium Decreased, Blood Creatine Phosphokinase Increased, Blood Creatine Phosphokinase Mb, Blood Creatinine Increased, Blood Lactate Dehydrogenase Increased, Blood Urea Increased
on Oct 14, 2009 Male patient from GERMANY , 84 years of age, was diagnosed with hyperlipidaemia, hypertension, ischaemic heart disease prophylaxis, benign prostatic hyperplasia, metabolic acidosis, renal failure chronic and was treated with Locol (View Usage). After Locol was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood calcium decreased, blood creatine phosphokinase increased, blood creatine phosphokinase mb, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased. Locol dosage: 40 Mg/day. During the same period patient was treated with DIOVAN HCT (0.5 Tab/day) (View Diovan Hct Review and Diovan Hct Label ), ACETYLSALICYLIC ACID (100 Mg/day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), ALFUZOSIN HCL (10 Mg/day) (View Alfuzosin Hcl Review and Alfuzosin Hcl Label ), BICANORM (1 G, Tid) (View Bicanorm Review and Bicanorm Label ), EINSALPHA (0.5 Ug/day) (View Einsalpha Review and Einsalpha Label ). Patient was hospitalized.

6107115-0 | Arrhythmia, Atrial Fibrillation, Bradyarrhythmia, Cardiac Arrest, Implantable Defibrillator Insertion, Long Qt Syndrome, Loss Of Consciousness, Pulse Absent, Resuscitation
Patient was taking Locol (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), atrial fibrillation (What is atrial fibrillation?), bradyarrhythmia, cardiac arrest (What is cardiac arrest?), implantable defibrillator insertion, long qt syndrome, loss of consciousness, pulse absent, resuscitation on Mar 02, 2009 from GERMANY Additional patient health information: Male patient , weighting 176.4 lb, . Locol dosage: 20 Mg, Qd. During the same period patient was treated with AVELOX (400 Mg, Qd) (View Avelox Review and Avelox Label ), DYNACIL COMP (Unk) (View Dynacil Comp Review and Dynacil Comp Label ), PASPERTIN (3x20 Drops, 3 In 1 Day) (View Paspertin Review and Paspertin Label ). Patient was hospitalized.

5601434-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, C-reactive Protein Increased, Gamma-glutamyltransferase Increased, Glomerular Filtration Rate Decreased, Hepatic Enzyme Increased
Adverse event was reported on Jan 17, 2008 by a Female patient taking Locol (View Usage) (Dosage: 1 Df, Qd) was diagnosed with hypercholesterolaemia, back pain (What is back pain?) and. Location: GERMANY , 68 years of age, weighting 145.5 lb, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, c-reactive protein increased, gamma-glutamyltransferase increased, glomerular filtration rate decreased, hepatic enzyme increased. During the same period patient was treated with KATADOLON (1 Df, Qd) (View Katadolon Review and Katadolon Label ).

5564320-X | Tendon Rupture
on Dec 12, 2007 Male patient from GERMANY , 66 years of age, weighting 176.4 lb, was diagnosed with hypercholesterolaemia and was treated with Locol (View Usage). After Locol was administered, patient had the following side effects: tendon rupture. Locol dosage: 1 Df, Qd.

5564314-4 | Bone Pain, Spinal Osteoarthritis, Tendon Rupture
on Dec 12, 2007 Male patient from GERMANY , 66 years of age, weighting 176.4 lb, was diagnosed with hypercholesterolaemia and was treated with Locol (View Usage). Patient experienced the following unwanted or unexpected effects: bone pain, spinal osteoarthritis, tendon rupture. Locol dosage: 80 Mg, Qd.

5563353-7 | Condition Aggravated, Gastrointestinal Infection, Haemorrhage, Headache, Knee Arthroplasty, Muscular Weakness, Myalgia, Paraesthesia
Patient was taking Locol (View Usage). Patient had the following side effects: condition aggravated, gastrointestinal infection, haemorrhage, headache (What is headache?), knee arthroplasty, muscular weakness, myalgia, paraesthesia on Dec 10, 2007 from GERMANY Additional patient health information: Female patient , 85 years of age, was diagnosed with hypercholesterolaemia, pain (What is pain?) and. Locol dosage: 80 Mg, Qd. During the same period patient was treated with OPIOIDS (View Opioids Review and Opioids Label ). Patient was hospitalized.

5388930-8 | Biliary Colic, Diarrhoea, Vomiting
Adverse event was reported on Jul 10, 2007 by a Female patient taking Locol (View Usage) (Dosage: 80 Mg, Qd) was diagnosed with hypercholesterolaemia, hypertension and. Location: GERMANY , 66 years of age, After Locol was administered, patient had the following side effects: biliary colic, diarrhoea, vomiting. During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), BELOC ZOK (View Beloc Zok Review and Beloc Zok Label ). Patient was hospitalized.

5338006-0 | Abdominal Pain, Appendicitis, Myalgia, Surgery
on May 25, 2007 Female patient from BRAZIL , 51 years of age, weighting 136.7 lb, was diagnosed with blood cholesterol, hypothyroidism and was treated with Locol (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), appendicitis (What is appendicitis?), myalgia, surgery (What is surgery?). Locol dosage: 80 Mg, Qhs. During the same period patient was treated with EUTHYROX (75 Ug/day) (View Euthyrox Review and Euthyrox Label ). Patient was hospitalized.

5196848-9 | Anxiety, Blood Creatine Phosphokinase Increased, Depersonalisation, Myalgia, Nervousness, Restlessness
on Dec 28, 2006 Female patient from GERMANY , 51 years of age, was diagnosed with hypercholesterolaemia and was treated with Locol (View Usage). Patient had the following side effects: anxiety (What is anxiety?), blood creatine phosphokinase increased, depersonalisation, myalgia, nervousness, restlessness. Locol dosage: 20 Mg, Qd. During the same period patient was treated with CELLCEPT (2000 Mg Daily) (View Cellcept Review and Cellcept Label ), DECORTIN H (5 Mg Daily) (View Decortin-h Review and Decortin-h Label ), BENALAPRIL (2.5 Mg Daily) (View Benalapril Review and Benalapril Label ), TRIAMTERENE AND HYDROCHLOROTHIAZIDE (0.5 Df Daily) (View Triamterene And Hydrochlorothiazide Review and Triamterene And Hydrochlorothiazide Label ).

5164406-8 | Lenticular Opacities, Myalgia
Patient was taking Locol (View Usage). After Locol was administered, patient had the following side effects: lenticular opacities, myalgia on Nov 20, 2006 from GERMANY Additional patient health information: Female patient , 66 years of age, was diagnosed with hypercholesterolaemia and. Locol dosage: 1 Df, Qd.

5112982-3 | Blood Creatine Phosphokinase Increased, Multi-organ Failure, Myoglobinaemia, Renal Failure, Rhabdomyolysis
Adverse event was reported on Sep 19, 2006 by a Female patient taking Locol (View Usage) (Dosage: 40 Mg Daily) was diagnosed with hyperlipidaemia and. Location: GERMANY , 81 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, multi-organ failure, myoglobinaemia, renal failure, rhabdomyolysis. Patient was hospitalized.

5106985-2 | Arthritis, Erythema Nodosum, Myalgia, Oedema Peripheral, Upper Respiratory Tract Infection
on Jul 20, 2006 Male patient from GERMANY , 50 years of age, weighting 172.0 lb, was diagnosed with hypercholesterolaemia and was treated with Locol (View Usage). Patient had the following side effects: arthritis (What is arthritis?), erythema nodosum, myalgia, oedema peripheral, upper respiratory tract infection. Locol dosage: 20 Mg Daily.

5105481-6 | Blood Glucose Decreased, Blood Lactate Dehydrogenase Increased, Blood Potassium Increased, Brain Abscess, Cerebrovascular Accident, Pneumonia
on May 30, 2005 Male patient from GERMANY , 67 years of age, weighting 143.3 lb, was diagnosed with hypercholesterolaemia and was treated with Locol (View Usage). After Locol was administered, patient had the following side effects: blood glucose decreased, blood lactate dehydrogenase increased, blood potassium increased, brain abscess, cerebrovascular accident, pneumonia (What is pneumonia?). Locol dosage: 80 Mg, Qd.

5094865-0 | Aortic Elongation, Arterial Occlusive Disease, Arterial Stenosis, Atelectasis, Blood Alkaline Phosphatase Increased, Cardiac Hypertrophy, Carotid Artery Stenosis, Coronary Artery Disease, Electrocardiogram Repolarisation Abnormality
Patient was taking Locol (View Usage). Patient experienced the following unwanted or unexpected effects: aortic elongation, arterial occlusive disease, arterial stenosis, atelectasis, blood alkaline phosphatase increased, cardiac hypertrophy, carotid artery stenosis, coronary artery disease (What is coronary artery disease?), electrocardiogram repolarisation abnormality on May 09, 2006 from GERMANY Additional patient health information: Male patient , 57 years of age, was diagnosed with hypercholesterolaemia, hypertension, dystonia (What is dystonia?) and. Locol dosage: 80 Mg, Qd. During the same period patient was treated with ASPIRIN (100 Mg Daily) (View Aspirin Review and Aspirin Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), BELOC (50 Mg Daily) (View Beloc Review and Beloc Label ), LISINOPRIL (5 Mg Daily) (View Lisinopril Review and Lisinopril Label ), INSIDON (50 Mg Daily) (View Insidon Review and Insidon Label ). Patient was hospitalized.

5093957-X | Gamma-glutamyltransferase Increased, Gastroduodenitis, Gastrooesophageal Sphincter Insufficiency
Adverse event was reported on May 09, 2006 by a Male patient taking Locol (View Usage) (Dosage: 80 Mg, Qd) was diagnosed with hypercholesterolaemia, depression (What is depression?) and. Location: GERMANY , 63 years of age, Patient had the following side effects: gamma-glutamyltransferase increased, gastroduodenitis, gastrooesophageal sphincter insufficiency. During the same period patient was treated with PAROXETINE HCL (40 Mg Daily) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), ISCOVER (75 Mg Daily) (View Iscover Review and Iscover Label ), AQUAPHOR /CAN/ (20 Mg Daily) (View Aquaphor /can/ Review and Aquaphor /can/ Label ), BISOPROLOL FUMARATE (5 Mg Daily) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), HALDOL (View Haldol Review and Haldol Label ).

5073907-2 | Blood Cholesterol Increased, Blood Triglycerides Increased
on Feb 09, 2005 Male patient from GERMANY , 54 years of age, weighting 174.2 lb, was diagnosed with hyperlipidaemia, diabetes mellitus and was treated with Locol (View Usage). After Locol was administered, patient had the following side effects: blood cholesterol increased, blood triglycerides increased. Locol dosage: 80 Mg, Qd. During the same period patient was treated with INSUMAN COMB (View Insuman Comb Review and Insuman Comb Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ).

5045721-5 | Blood Creatine Phosphokinase Increased, Bone Pain, Muscle Atrophy, Myalgia, Myositis
on Jun 27, 2006 Male patient from GERMANY , 69 years of age, was treated with Locol (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, bone pain, muscle atrophy, myalgia, myositis (What is myositis?). Locol dosage: . During the same period patient was treated with CERTICAN (View Certican Review and Certican Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ).

5026119-2 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Gamma-glutamyltransferase Increased, Liver Function Test Abnormal, Malaise, Syncope
Patient was taking Locol (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, liver function test abnormal, malaise, syncope on May 16, 2006 from GERMANY Additional patient health information: Female patient , 38 years of age, weighting 121.3 lb, was diagnosed with hypercholesterolaemia and. Locol dosage: 80 Mg, Qd. Patient was hospitalized.

4969100-1 | Extrasystoles, Myalgia
Adverse event was reported on Feb 09, 2006 by a Female patient taking Locol (View Usage) (Dosage: 20 Mg, Qd) was diagnosed with low density lipoprotein increased and. Location: GERMANY , 65 years of age, weighting 136.7 lb, After Locol was administered, patient had the following side effects: extrasystoles, myalgia.

4931739-7 | Bone Pain, Spinal Osteoarthritis, Tendon Rupture
on Feb 09, 2006 Male patient from GERMANY , 66 years of age, weighting 176.4 lb, was diagnosed with hypercholesterolaemia and was treated with Locol (View Usage). Patient experienced the following unwanted or unexpected effects: bone pain, spinal osteoarthritis, tendon rupture. Locol dosage: 80 Mg, Qd.

4917355-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Cholestasis, Eosinophilia, Gamma-glutamyltransferase Increased, Hepatotoxicity, Hyperbilirubinaemia
on Nov 07, 2005 Female patient from GERMANY , 72 years of age, weighting 134.5 lb, was diagnosed with hyperlipidaemia and was treated with Locol (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cholestasis, eosinophilia, gamma-glutamyltransferase increased, hepatotoxicity, hyperbilirubinaemia. Locol dosage: 40 Mg, Qd. During the same period patient was treated with BETA BLOCKING AGENTS (View Beta Blocking Agents Review and Beta Blocking Agents Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

4912328-7 | Tendon Rupture
Patient was taking Locol (View Usage). After Locol was administered, patient had the following side effects: tendon rupture on Feb 09, 2006 from GERMANY Additional patient health information: Male patient , 66 years of age, weighting 176.4 lb, was diagnosed with hypercholesterolaemia and. Locol dosage: 80 Mg, Qd.

4912327-5 | Extrasystoles, Myalgia
Adverse event was reported on Feb 09, 2006 by a Female patient taking Locol (View Usage) (Dosage: 20 Mg, Qd) was diagnosed with low density lipoprotein increased and. Location: GERMANY , 65 years of age, weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: extrasystoles, myalgia.

4902840-9 | Periodontitis, Tooth Loss
on Jan 19, 2006 Male patient from GERMANY , 49 years of age, weighting 169.8 lb, was diagnosed with hypercholesterolaemia and was treated with Locol (View Usage). Patient had the following side effects: periodontitis, tooth loss. Locol dosage: 80 Mg/day.

4898500-3 | Blood Creatine Phosphokinase Increased, Facial Paresis, Myalgia, Transient Ischaemic Attack
on Dec 14, 2005 Male patient from GERMANY , 79 years of age, weighting 180.8 lb, was diagnosed with hypercholesterolaemia and was treated with Locol (View Usage). After Locol was administered, patient had the following side effects: blood creatine phosphokinase increased, facial paresis, myalgia, transient ischaemic attack. Locol dosage: 40 Mg, Qd. Patient was hospitalized.

4898499-X | Paraesthesia, Polyneuropathy
Patient was taking Locol (View Usage). Patient experienced the following unwanted or unexpected effects: paraesthesia, polyneuropathy on Dec 15, 2005 from GERMANY Additional patient health information: Female patient , 44 years of age, weighting 158.7 lb, was diagnosed with hypercholesterolaemia and. Locol dosage: 80 Mg, Qd. During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), PRAVASIN (20 Mg, Qd) (View Pravasin Review and Pravasin Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ).

4887445-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Cholestasis, Eosinophilia, Gamma-glutamyltransferase Increased, Hepatotoxicity, Hyperbilirubinaemia
Adverse event was reported on Nov 07, 2005 by a Female patient taking Locol (View Usage) (Dosage: 40 Mg, Qd) was diagnosed with hyperlipidaemia and. Location: GERMANY , 72 years of age, weighting 134.5 lb, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cholestasis, eosinophilia, gamma-glutamyltransferase increased, hepatotoxicity, hyperbilirubinaemia. During the same period patient was treated with BETA BLOCKING AGENTS (View Beta Blocking Agents Review and Beta Blocking Agents Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

4883395-4 | Diabetes Mellitus, Folliculitis, Local Swelling, Pruritus, Renal Failure Acute
on Jul 15, 2005 Female patient from GERMANY , 77 years of age, weighting 178.6 lb, was diagnosed with hypercholesterolaemia and was treated with Locol (View Usage). After Locol was administered, patient had the following side effects: diabetes mellitus, folliculitis, local swelling, pruritus, renal failure acute. Locol dosage: 80 Mg, Qd. Patient was hospitalized.

4860443-9 | Glaucoma
on Dec 12, 2005 Male patient from GERMANY , 40 years of age, was diagnosed with prophylaxis and was treated with Locol (View Usage). Patient experienced the following unwanted or unexpected effects: glaucoma (What is glaucoma?). Locol dosage: 80 Mg, Qd.

4852387-3 | Condition Aggravated, Muscle Spasms, Musculoskeletal Stiffness, Restlessness, Sleep Apnoea Syndrome, Sleep Disorder
Patient was taking Locol (View Usage). Patient had the following side effects: condition aggravated, muscle spasms, musculoskeletal stiffness, restlessness, sleep apnoea syndrome, sleep disorder (What is sleep disorder?) on Oct 24, 2005 from GERMANY Additional patient health information: Male patient , 40 years of age, was diagnosed with hypercholesterolaemia and. Locol dosage: 80 Mg, Qd. During the same period patient was treated with EZETROL (1 Df, Qd) (View Ezetrol Review and Ezetrol Label ), OMACOR (1 Df, Qd) (View Omacor Review and Omacor Label ), SELENIUM SULFIDE (800 Mg, Bid) (View Selenium Sulfide Review and Selenium Sulfide Label ), VIGANTOLETTEN (View Vigantoletten Review and Vigantoletten Label ). Patient was hospitalized.

4844489-2 | Abdominal Pain, Appendicitis, Myalgia, Surgery
Adverse event was reported on Nov 20, 2005 by a Female patient taking Locol (View Usage) (Dosage: 80 Mg, Unk) was diagnosed with blood cholesterol, hypothyroidism and. Location: BRAZIL , weighting 136.7 lb, After Locol was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), appendicitis (What is appendicitis?), myalgia, surgery (What is surgery?). During the same period patient was treated with EUTHYROX (75 Mcg/day) (View Euthyrox Review and Euthyrox Label ). Patient was hospitalized.

4841846-5 | Acholia, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Cholestasis, Eosinophilia, Gamma-glutamyltransferase Increased, Hepatotoxicity
on Nov 07, 2005 Female patient from GERMANY , 72 years of age, weighting 134.5 lb, was diagnosed with hyperlipidaemia and was treated with Locol (View Usage). Patient experienced the following unwanted or unexpected effects: acholia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cholestasis, eosinophilia, gamma-glutamyltransferase increased, hepatotoxicity. Locol dosage: 40 Mg, Qd.

4829527-5 | Anisometropia, Cataract, Conjunctivitis, Constipation, Diplopia, Dyspepsia, Gastrointestinal Pain, Impaired Driving Ability
on Aug 11, 2003 Male patient from GERMANY , 54 years of age, weighting 172.0 lb, was diagnosed with hypercholesterolaemia, haemorrhoids and was treated with Locol (View Usage). Patient had the following side effects: anisometropia, cataract (What is cataract?), conjunctivitis, constipation (What is constipation?), diplopia, dyspepsia, gastrointestinal pain, impaired driving ability. Locol dosage: 40 Mg, Qd. During the same period patient was treated with CONCOR (2.5 Mg Daily) (View Concor Review and Concor Label ), NORVASC (5 Mg Daily) (View Norvasc Review and Norvasc Label ), ASPIRIN (100 Mg Daily) (View Aspirin Review and Aspirin Label ), LORZAAR (50 Mg Daily) (View Lorzaar Review and Lorzaar Label ), OMEPRAZOLE (Unk, Prn) (View Omeprazole Review and Omeprazole Label ), TAVOR (View Tavor Review and Tavor Label ), FAKTU (Unk, Prn) (View Faktu Review and Faktu Label ).

4829502-0 | Acholia, Cholestasis, Eosinophilia, Hepatotoxicity, Hyperbilirubinaemia, Hypersensitivity, Liver Disorder, Pruritus, Pyrexia
Patient was taking Locol (View Usage). After Locol was administered, patient had the following side effects: acholia, cholestasis, eosinophilia, hepatotoxicity, hyperbilirubinaemia, hypersensitivity, liver disorder, pruritus, pyrexia on Nov 07, 2005 from GERMANY Additional patient health information: Female patient , 72 years of age, . Locol dosage: 40 Mg, Qd.

4814544-1 | Condition Aggravated, Muscle Spasms, Musculoskeletal Stiffness, Restlessness, Sleep Apnoea Syndrome
Adverse event was reported on Oct 24, 2005 by a Male patient taking Locol (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia and. Location: GERMANY , 40 years of age, Patient experienced the following unwanted or unexpected effects: condition aggravated, muscle spasms, musculoskeletal stiffness, restlessness, sleep apnoea syndrome. During the same period patient was treated with EZETROL (View Ezetrol Review and Ezetrol Label ). Patient was hospitalized.

4805732-9 | Diabetes Mellitus, Folliculitis, Local Swelling, Pruritus, Renal Failure Acute
on Jul 15, 2005 Female patient from GERMANY , 77 years of age, weighting 178.6 lb, was diagnosed with hypercholesterolaemia and was treated with Locol (View Usage). Patient had the following side effects: diabetes mellitus, folliculitis, local swelling, pruritus, renal failure acute. Locol dosage: 80 Mg, Qd. Patient was hospitalized.

4794494-X | Anisometropia, Cataract, Constipation, Diplopia, Dyspepsia, Gastrointestinal Pain, Impaired Driving Ability, Lens Disorder
on Aug 11, 2003 Male patient from GERMANY , 54 years of age, weighting 172.0 lb, was diagnosed with hypercholesterolaemia, haemorrhoids and was treated with Locol (View Usage). After Locol was administered, patient had the following side effects: anisometropia, cataract (What is cataract?), constipation (What is constipation?), diplopia, dyspepsia, gastrointestinal pain, impaired driving ability, lens disorder. Locol dosage: 40 Mg, Qd. During the same period patient was treated with CONCOR (2.5 Mg Daily) (View Concor Review and Concor Label ), NORVASC (5 Mg Daily) (View Norvasc Review and Norvasc Label ), ASPIRIN (100 Mg Daily) (View Aspirin Review and Aspirin Label ), LORZAAR (50 Mg Daily) (View Lorzaar Review and Lorzaar Label ), OMEPRAZOLE (Unk, Prn) (View Omeprazole Review and Omeprazole Label ), TAVOR (View Tavor Review and Tavor Label ), FAKTU (Unk, Prn) (View Faktu Review and Faktu Label ).

4784939-3 | Tendon Rupture
Patient was taking Locol (View Usage). Patient experienced the following unwanted or unexpected effects: tendon rupture on Sep 26, 2005 from GERMANY Additional patient health information: Male patient , 66 years of age, weighting 176.4 lb, was diagnosed with hypercholesterolaemia and. Locol dosage: 1 Df, Qd.

4777431-3 | Anorexia, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Chromaturia, Faeces Discoloured, Fatigue, Gamma-glutamyltransferase Increased, Jaundice, Liver Function Test Abnormal
Adverse event was reported on Jul 26, 2005 by a Female patient taking Locol (View Usage) (Dosage: 80 Mg, Qd) was diagnosed with hypercholesterolaemia, hypertension, gastritis and. Location: GERMANY , 67 years of age, weighting 132.3 lb, Patient had the following side effects: anorexia, blood alkaline phosphatase increased, blood bilirubin increased, chromaturia, faeces discoloured, fatigue, gamma-glutamyltransferase increased, jaundice (What is jaundice?), liver function test abnormal. During the same period patient was treated with ACTIVELLE (0.5 Df, Qd) (View Activelle Review and Activelle Label ), NORVASC (5 Mg, Qd) (View Norvasc Review and Norvasc Label ), DILATREND (12.5 Mg, Qd) (View Dilatrend Review and Dilatrend Label ), RANITIDINE (150 Mg, Qd) (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

4769932-9 | Acidosis, Asthenia, Exercise Tolerance Decreased, Impaired Gastric Emptying, Muscle Spasms, Tachypnoea, Vomiting
on Sep 09, 2005 Male patient from GERMANY , 51 years of age, was diagnosed with type iia hyperlipidaemia and was treated with Locol (View Usage). After Locol was administered, patient had the following side effects: acidosis, asthenia, exercise tolerance decreased, impaired gastric emptying, muscle spasms, tachypnoea, vomiting. Locol dosage: 80 Mg, Qd.

4766132-3 | Hepatic Steatosis, Transaminases Increased
on Sep 06, 2005 Male patient from GERMANY , 71 years of age, weighting 207.2 lb, was diagnosed with hypercholesterolaemia and was treated with Locol (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic steatosis, transaminases increased. Locol dosage: 1 Df, Qd. During the same period patient was treated with METOPROLOL SUCCINATE (1 Df, Bid) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), DELIX (5 Mg, Qd) (View Delix Review and Delix Label ).

4734875-3 | Cardiac Operation, Erythema, Oedema Peripheral, Procedural Site Reaction, Scar, Skin Necrosis, Vasculitis
Patient was taking Locol (View Usage). Patient had the following side effects: cardiac operation, erythema, oedema peripheral, procedural site reaction, scar (What is scar?), skin necrosis, vasculitis (What is vasculitis?) on Apr 11, 2005 from GERMANY Additional patient health information: Female patient , 73 years of age, was diagnosed with hyperlipidaemia and. Locol dosage: . During the same period patient was treated with VERAHEXAL (View Verahexal Review and Verahexal Label ), NITRO SPRAY (View Nitro-spray Review and Nitro-spray Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LIPIDIL (View Lipidil Review and Lipidil Label ), EZETROL (View Ezetrol Review and Ezetrol Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ). Patient was hospitalized.